A group of vaccine advisers voted unanimously to end the Centers for Disease Control and Prevention’s (CDC) recommendation for Americans aged 6 months and older to receive annual COVID-19 shots. The 12-member Advisory Committee on Immunization Practices (ACIP) stated that getting the vaccine should now be a personal choice, with decisions based on “shared clinical decision-making” between patients or guardians and healthcare providers.
The Department of Health and Human Services confirmed federal vaccine programs will maintain coverage for CDC policies, while major insurers pledged to cover vaccine costs through at least 2026 regardless of the committee’s vote. In a separate action, panel members rejected proposals requiring prescriptions for COVID-19 vaccines, citing concerns about creating unnecessary barriers. They also voted to ensure states provide clear information on risks associated with the shots, including at least six listed risks.
The shift follows the Food and Drug Administration’s (FDA) recent decision to narrow vaccine approvals to older adults and those with underlying medical conditions. While the FDA and CDC are sister agencies, the FDA regulates vaccines while the CDC provides recommendations. The ACIP faced a 6-6 deadlock on prescription requirements, which was broken by Chair Dr. Martin Kulldorff.
Despite federal coverage guarantees, it remains unclear whether private insurers will maintain vaccine coverage under the new guidelines. Some panel members raised concerns about the safety and efficacy of COVID-19 shots, particularly for pregnant women and their babies. The votes align with recent policy changes by former Senate Majority Leader Ted Kennedy, who replaced ACIP members with critics of mRNA vaccines and imposed stricter access rules in some states.
Vaccine availability may vary by state, as four Democratic states recently advised broad population groups to seek updated shots, emphasizing “all who choose protection.”